Pharmafile Logo

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

- PMLiVE

[19th October 2022] – Resonant Group today announced the appointment of Miranda Dini as Chief Operating Officer and Head of Healthcare Communications. In this role she will have responsibility for Bedrock Healthcare Communications and Anthem Public Relations, as well as any other future acquisitions and strategic partnerships within the healthcare communications space.

Resonant is a privately owned group of award-winning specialist healthcare agencies – including Bedrock, Anthem and Origins, that share a common belief that lives can be transformed through better health communication. In this newly created role, Miranda will report to David Youds, Founder and CEO of Resonant Group.  She joins Resonant from AVENIR GLOBAL, where she was a Board Director and Global Head of Healthcare for the firm, as well as Managing Partner of AXON Europe. Throughout her tenure, Miranda was a driving force behind the company’s growth and reputation. In March 2022, she was recognised as one of Women In PR’s 45 Over 45.

“This is a vital leadership role that will help propel us forward, boosting growth while enhancing service delivery across our healthcare communications businesses,” said David Youds. “Miranda has a deserved reputation for building successful businesses across all healthcare disciplines and brings a rare breadth and depth of expertise across the industry; her appointment speaks volumes about Resonant’s ambition and potential.”

“I’m delighted to join Resonant Group and have the rare opportunity to be part of a fully independent group of this size and ambition with values that so closely align with my beliefs,” said Miranda. “Resonant Group is at such an exciting stage of its journey, and I believe the best is yet to come as we further enhance the Group’s already-compelling multi-disciplinary offer.”

Alongside Miranda’s appointment, the Group is announcing two further leadership changes which will support Resonant’s plans for growth.

Stephen Marchant is taking up the role of Managing Director of Bedrock Healthcare Communications; his extensive previous experience in this role within both Chameleon and HCG make him the ideal person to take this business forward.

Marie Little is stepping into the newly created role of Group Commercial Head and will be working across the Group to support business development and group-level commercial relationships.

“As an organisation, we recognise that mobility of roles, even at a very senior level, is something that can be incredibly powerful in making sure all of us are playing to our strengths,” said David Youds. “These two moves send a signal to our teams that Resonant Group is focused on developing fulfilling and satisfying careers for our people at all levels.”

For further information, contact:

Marie Little, Group Commercial Head

+44(0)7425 521235

This content was provided by Origins – The Patient Focused Specialists

Company Details

 Latest Content from  Origins – The Patient Focused Specialists 

Origins’ Solutions Offering Explained

Providing patient solutions that are wanted, needed, accessible, and fit for purpose can help companies to increase the value and success of their products and gain respect and recognition for...

Origins’ Knowledge Centre

A collection of resources including webinar recordings, publications and short videos to help you be more patient focussed

Origins Insights Offering Explained

Origins believe that the patient voice not only should but must be included at all stages of the product lifecycle, we believe the question is no longer about why, but...

Introduction to Origins

In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the...

Origins’ Strategy Offering Explained

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

End-to-end patient strategy: Making a treatment for patients, with patients

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy...

ORIGINS cements its specialist position with a truly patient focused offering

Origins are the patient focused specialists that create and deliver strategy, insights, experience data and solutions across the product lifecycle

FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

Origins announces the first speaker on the panel of our upcoming webinar

ORIGINS INSIGHTS EVOLVES INTO PATIENT SPECIALIST AGENCY

Deeper focus on patient engagement across the pharma/biotech product lifecycle

Mark Corbett explains why Origins is evolving

Resonant Group Chief Innovation Officer, Mark Corbett has released a video explain why Origins is evolving from a Patient Insights agency to a Patient Focused Specialist agency.